Our complimentary white papers draw on our primary research findings to provide you information on critical life sciences topics. Please fill out the short form accompanying each white paper in the list below. You will then be directed to links to the downloadable PDFs.
Click the download button below to get access to a complimentary white paper.
If you have questions, call (919) 403-6583.
Latest White Papers
Sponsor-CRO Relationships: The Benefits and Challenges of Collaborating with 3rd-Party Providers 2015
Contract research organizations (CROs) provide instrumental support for the design and execution-based aspects of sponsors’ clinical research. Many pharmaceutical and device companies recruit CROs to help them overcome a challenging clinical environment. This environment includes growing R&D costs, pricing pressures and evolving regulatory guidelines. This paper provides a glimpse into sponsor and CRO relationships, including what responsibilities sponsors most often outsource, how CROs may help sponsors propel existing clinical strategies, and how these two teams can work together to overcome clinical trial challenges.
Patient-Centric Marketing: Using Social and Digital Channels to Cultivate Customer-Focused Strategies 2015
As the commercial landscape shifts to accommodate more competitors and healthcare stakeholders, pharmaceutical companies turn their focus to better include end users’ perspectives. As patients become more informed and active in making healthcare decisions, pharmaceutical companies benefit from reaching out to these customers directly. Patient-centric marketing strategies are an integral part of commercial mixes that allow companies to better encourage brand loyalty and adherence among their target audiences.
Should IIT Areas of Interest be Publicly Available? Insights from ExL’s MASS East 2015 2015
When it comes to disseminating their areas of interest to potential investigators, investigator-initiated trial (IIT) teams walk a fine line between transparency and compliance concerns. Areas of interest are critical for life science companies to evaluate IIT proposals and for investigators to understand what types of studies the company will fund. However, executives debate whether or not the areas of interest should be publicly available on the company’s website. IIT teams that post areas of interest in the public domain promote transparency about research gaps and allow a wider range of researchers to submit proposals. But they also risk giving away competitive intelligence and inviting potential compliance inquiries about off-label promotion. IIT teams can balance these concerns by posting very broad topics online, putting specific areas of interest behind an investigator registration page, and/or by entrusting areas of interest to medical science liaisons.
Understanding the Importance of Mobile Health for Pharma 2015
Mobile health offers the life sciences industry far-reaching capabilities to connect with multiple healthcare stakeholders, including physicians, patients and caregivers. Consequently, mobile applications serve a number of purposes: from providing consumer groups with much-needed medical information to encouraging patients to maintain their treatment regimens. However, as this paper will discuss, ensuring that mobile applications provide long-term value begins with building concrete strategies that consider initiatives’ end goals and target audiences.